577 related articles for article (PubMed ID: 3314301)
1. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
Johnston WW
Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic characterization of lung cancers in fine needle aspiration biopsies using monoclonal antibody B72.3.
Johnston WW; Szpak CA; Thor A; Schlom J
Cancer Res; 1986 Dec; 46(12 Pt 1):6462-70. PubMed ID: 3022920
[TBL] [Abstract][Full Text] [Related]
3. Applications of immunocytochemistry to clinical cytology.
Johnston WW; Szpak CA; Thor A; Simpson JF; Schlom J
Cancer Invest; 1987; 5(6):593-611. PubMed ID: 3327572
[TBL] [Abstract][Full Text] [Related]
4. Use of a monoclonal antibody (B72.3) as an immunocytochemical adjunct to diagnosis of adenocarcinoma in human effusions.
Johnston WW; Szpak CA; Lottich SC; Thor A; Schlom J
Cancer Res; 1985 Apr; 45(4):1894-900. PubMed ID: 3884146
[TBL] [Abstract][Full Text] [Related]
5. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.
Molinolo A; Simpson JF; Thor A; Schlom J
Cancer Res; 1990 Feb; 50(4):1291-8. PubMed ID: 2297774
[TBL] [Abstract][Full Text] [Related]
6. Use of a monoclonal antibody (B72.3) as a novel immunohistochemical adjunct for the diagnosis of carcinomas in fine needle aspiration biopsy specimens.
Johnston WW; Szpak CA; Lottich SC; Thor A; Schlom J
Hum Pathol; 1986 May; 17(5):501-13. PubMed ID: 2422108
[TBL] [Abstract][Full Text] [Related]
7. Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1 and B6.2) with cells in human malignant and benign effusions.
Szpak CA; Johnston WW; Lottich SC; Kufe D; Thor A; Schlom J
Acta Cytol; 1984; 28(4):356-67. PubMed ID: 6205527
[TBL] [Abstract][Full Text] [Related]
8. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3.
Thor A; Gorstein F; Ohuchi N; Szpak CA; Johnston WW; Schlom J
J Natl Cancer Inst; 1986 Jun; 76(6):995-1006. PubMed ID: 3520078
[TBL] [Abstract][Full Text] [Related]
9. Complementary reactivities of anti-carcinoembryonic antigen and antitumor-associated glycoprotein 72 monoclonal antibodies in lung carcinomas.
Battista P; Muraro R; Mammarella S; Curia MC; Colasante A; Rosini S; Lesti G; Sacco R; French D; Frati L
Cancer Res; 1990 Nov; 50(21):6987-94. PubMed ID: 1698547
[TBL] [Abstract][Full Text] [Related]
10. The use of monoclonal antibody B72.3 in the management of gynecologic malignancies.
Simpson J; Schlom J
Yale J Biol Med; 1988; 61(4):351-66. PubMed ID: 3055701
[TBL] [Abstract][Full Text] [Related]
11. Detection of adenocarcinoma in peritoneal washings by staining with monoclonal antibody B72.3.
Szpak CA; Soper JT; Thor A; Schlom J; Johnston WW
Acta Cytol; 1989; 33(2):205-14. PubMed ID: 2648721
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemistry with monoclonal antibody B72.3 as an adjunct in the cytologic diagnosis of pancreatic carcinoma.
Ness MJ; Pour PM; Tempero MA; Linder J
Mod Pathol; 1988 Jul; 1(4):279-83. PubMed ID: 2467286
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
Edwards DP; Grzyb KT; Dressler LG; Mansel RE; Zava DT; Sledge GW; McGuire WL
Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721
[TBL] [Abstract][Full Text] [Related]
14. Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen.
Muraro R; Kuroki M; Wunderlich D; Poole DJ; Colcher D; Thor A; Greiner JW; Simpson JF; Molinolo A; Noguchi P
Cancer Res; 1988 Aug; 48(16):4588-96. PubMed ID: 3396010
[TBL] [Abstract][Full Text] [Related]
15. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3.
Thor A; Ohuchi N; Szpak CA; Johnston WW; Schlom J
Cancer Res; 1986 Jun; 46(6):3118-24. PubMed ID: 3516392
[TBL] [Abstract][Full Text] [Related]
16. Surface expression of tumor-associated antigens in primary cultured human colonic epithelial cells from carcinomas, benign tumors, and normal tissues.
Friedman E; Thor A; Hand PH; Schlom J
Cancer Res; 1985 Nov; 45(11 Pt 2):5648-55. PubMed ID: 2413994
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of immunoreactivity of normal tissues from dogs, using monoclonal antibody B72.3.
Clemo FA; DeNicola DB; Zimmermann JL
Am J Vet Res; 1994 Aug; 55(8):1139-47. PubMed ID: 7978655
[TBL] [Abstract][Full Text] [Related]
18. Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted carcinoembryonic antigen reactivity.
Thor A; Muraro R; Gorstein F; Ohuchi N; Viglione M; Szpak CA; Johnston WW; Schlom J
Cancer Res; 1987 Jan; 47(2):505-12. PubMed ID: 2431771
[TBL] [Abstract][Full Text] [Related]
19. Expression of a melanoma-tumor-associated antigen as demonstrated by a monoclonal antibody (D6.1) in cytopathologic preparations of human tumor cells from effusions and needle aspirates.
Johnston WW; Borowitz MJ; Stuhlmiller GM; Seigler HF
Anal Quant Cytol Histol; 1985 Mar; 7(1):72-80. PubMed ID: 3890654
[TBL] [Abstract][Full Text] [Related]
20. Use of monoclonal antibody B72.3 as a marker of metastatic carcinoma cells in neoplastic effusions.
Betta PG; Pavesi M; Pastormerlo M; Tallarida F; Bellingeri D; Bocca R
Pathologica; 1991; 83(1083):99-104. PubMed ID: 1866206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
